NVCT – nuvectis pharma, inc. (US:NASDAQ)
Stock Stats
News
Nuvectis Pharma: An Interesting Early Pipeline Does Not Justify A Buy [Seeking Alpha]
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference [Yahoo! Finance]
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
Nuvectis Pharma, Inc. (NASDAQ: NVCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Form 4 Nuvectis Pharma, Inc. For: May 14 Filed by: BENTSUR RON
Form 4 Nuvectis Pharma, Inc. For: May 10 Filed by: BENTSUR RON
Form 4 Nuvectis Pharma, Inc. For: May 10 Filed by: Poradosu Enrique
Form 4 Nuvectis Pharma, Inc. For: May 10 Filed by: Shemesh Shay
Form 10-Q Nuvectis Pharma, Inc. For: Mar 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.